• Article highlight
  • Article tables
  • Article images

Article History

Received : 01-02-2024

Accepted : 22-02-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 554

PDF Downloaded: 410


Get Permission Sarode and Gautam: Evaluation of betulin for hair growth promoting activity in rats


Introduction

Due to the general interest in an individual's body form, hair, cosmetics, and attire, both men and women are under pressure from society to look a certain way.1 Numerous studies on hair loss demonstrate the significant role that hair plays in social and sexual communication as well as the appearance of the human body.2

One of the essential components of the body, hair is an appendage that provides protection and is derived from the ectoderm of the skin. It plays a significant role in the human body's allure.3

Alopecia

Alopecia is a generic term that is generally used for hair fall and loss. Hair loss is a natural daily phenomenon, but this shedding of hair cannot be the main cause of hair loss.4

Types of Alopecia

Alopecia can be classified by different ways

A) According to their causes alopecia may be classified as follows-

  1. Non-scarring Alopecia: It happens because of genetic issues, getting older, taking medications like contraceptives and anti-cancer chemotherapeutic drugs, applying chemical treatments topically like hair dyes, permanent wave solutions, and straighteners, getting sick, having allergies, or getting infections in the hair follicles.5

  2. Scarring Alopecia: It can happen as a result of trauma, which frequently destroys follicles, or burns (accidental or after surgery from cryosurgery or laser surgery).5

B) According to factor responsible alopecia may be classified as follows-

Androgenetic Alopecia (AGA)

AGA is a common hereditary thinning of hair induced by androgens in genetically susceptible and this condition is known in men as common baldness and as female pattern baldness in women.

AGA is major type of scalp hair loss that affects 60 70% of the population. It affects

50% of male by the age of 50 years and up to 70% of all males in the later life.

25% of women by the age of 49 years and 41% at the age of 69 years.

It is characterized by the miniaturization of the large, thick pigmented terminal hair with a diameter of > 0.03 mm to small, fine, non-pigmented vellus hair with a diameter of ≤ 0.03 mm. This characteristic of AGA is due to premature entry of the hair follicle into the catagen phase and the delay in the transition from the telogen phase to the anagen phase, resulting in the shortening of the anagen phase. 5

Figure 1

Characteristic of AGA.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image1.png
  1. Alopecia Areata: Alopecia areata is characterized by patchy scalp baldness. Most common reasons of alopecia areata are pregnancy, hormone pills, thyroids disorder, and sexually transmitted disease like syphilis, gonorrehea, anemia and arthritis.6

  2. Alopecia Universalis: Alopecia universalis is a type of alopecia in which total body hair loss occurs Patients are usually healthy, it occurs due to the thyroid disease and vitiligo and hair loss all over the body.6

Factors related to Hair Loss

There are various factors which affects growth of hairs.7

Table 1

Factors affecting to hair loss

Factors

Description

Major physical–emotional stress

Surgery, severe illness, diet or nutrition changes and emotional stress can cause hair loss.

Chemotherapy

Parkinson medications, anti-ulcer drugs, anticoagulants, agents for gout, anticonvulsants for epilepsy, antidepressants, beta-blocker drugs, anti-thyroid agents, anti-neoplastics, blood thinners, male hormones.

Smoking

Tobacco smoke damages the lining of blood vessels, leading to less production of nitric oxide and thus inducing hair loss.

Genetic pre-disposition

Genetic component to androgenetic hair loss exists (polygenic inheritance)

Cardiovascular

Diseases high levels of LDL in cardiac patients are converted to 5-alpha reductase enzyme, which produces DHT from testosterone, causing hair loss.

Dihydro- testosterone (DHT)

Increased level of DHT (the testosterone metabolite) shortens the hair cycle and progressively minimizes scalp follicles and this may be due to the atherosclerotic process blocking the microvasculature that nourishes the hair follicles.

Drug Profile

Name of Drug: BetulinIUPAC Name: Lup-20(29)-ene-3β,28-diolChemical Formula: C30H50O2

Structure of betulin

Figure 2

Structure of bitulin

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image2.png

Category of Chemical Constituent: Pentacyclic triterpene alcohol with lupane skeleton

Source: The major source of betulin is outer bark of Birch Trees. A lesser amount can be found in the skin and leaves of birches.8

Mechanism of Action: Betulin inhibit the maturation of Sterol Regulatory Element Binding Protein (SREBP) and thus decrease the biosynthesis of cholesterol and fatty acids. It decreases the lipid contents in serum, tissues and increases insulin sensitivity.9

Pharmacological Activity: Betulin has shown antimicrobial, anti-bacterial, antiviral, anti-HIV, anti-inflammatory, anti-diabetic, hepatoprotective, gastroprotective, anti-proliferative, anti-hyperlipidaemic, anti-malarial and anti-cancer activities.10

Materials and Methods

Procurement of animals & their diet

The Albino rats (Wistar strain) of age 12-16 months, weighing between 200 ± 30g, were procured from the animal house of Institute of Pharmaceutical Education and Research (I.P.E.R.), Wardha. The animals were housed in the polypropylene cage at a temperature of 24º ± 2ºC with the relative humidity of 40-60% and 12 hour light / dark cycle. Animals were fed with balanced diet and water during the complete experimental period. The experimental protocol was approved by the Institutional Animal Ethics Committee of Institute of Pharmaceutical Education and Research, Wardha (Registration Number 535/PO/Re/02/CPCSEA) on dated 01.12.2018 with Protocol No. IAEC/2018-19/02

Preparation of Testosterone (Sustanon 100)

The dose of Testosterone 0.5 mg/kg, by subcutaneous route for 21 days was selected on the basis of literature survey.11

Testosterone (Sustanon 100) 100 mg injection was diluted with 200 ml arachis oil, this was able to produce concentration 0.5mg/ml.

The dose of Testosterone (0.5 mg/kg, s.c) was calculated according to the body weight of the animal and was administered for the preparation of alopecia model.

Preparation of 3% Minoxidil Solution

The topical 3% minoxidil solution was selected on the basis of literature survey. 12

3% Minoxidil solution was prepared by using propylene glycol, alcohol and water in the ratio of 5:3:2 and was applied to the animals topically for 28 days.

Preparation of Betulin

The dose of betulin 10mg/kg, 20mg/kg, 40mg/kg p.o and betulin topical was selected on the basis of literature survey. 13

The dose of betulin (10mg/kg, 20kg/kg, 40mg/kg) was calculated according to the body weight of the animal and was administered to the rats per orally (p.o) for 28 days.

The betulin topical (3mg/ml) solution was prepared by using olive oil and applied topically for 28 days. The drug solutions for the studies were freshly prepared.

Experimental Design

Table 2

Differental groups of experimental animals

Sr. No.

Group

Treatment

Doses and Routes

No. of Animals

1

Group I (Normal)

Saline

Saline solution, p.o.

6

2

Group II (Control)

Testosterone

0.5mg/kg, s.c.

6

3

Group III (Standard)

Minoxidil

Topical

6

4

Group IV (Test I)

Betulin

10mg/kg, p.o.

6

5

Group V (Test II)

Betulin

20mg/kg, p.o.

6

6

Group VI (Test III)

Betulin

40mg/kg, p.o.

6

7

Group VII (Test IV)

Betulin

Topical (3mg/ml)

6

8

Group VIII (Test + Std.)

Betulin + Minoxidil

10mg/kg, p.o. + topical

6

After induction period of 21 days i.e. on 22ndday and after treatment period of 28 days i.e. on 49thday the initial and final weight were taken respectively. Blood was withdrawal by retro-orbital plexus method and biochemical parameters were performed on 22nd and 49th day. 3 mm area of skin of two rats from each group were taken on 22nd day and 49th day. Samples were stored in 10% formalin solution and sent for histopathological studies.

Induction of Alopecia

Figure 3

Photograph of animal showing natural hair.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image3.png
Figure 4

Photograph of animal showing alopecia after treating with Testosterone.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image4.png

Results

Determination of physiological parameters

Measurement of body weight

The body weight of animals of each group was measured on 1st day i.e. initial weight, on 22nd day after induction of alopecia i.e. intermediate weight and on 49th day after treatment i.e. final weight.

Table 3

Observation of body weight

Group No.

Treatment

Body Weight

1st Day

22nd Day

49th Day

I

Normal (Saline Solution)

339.66 ± 19.68

340 ± 17.49

346.16± 17.34

II

Control (Testosterone)

287.5 ± 8.71

354.83 ± 11.18@

353.5 ± 9.78@

III

Standard (Minoxidil)

317.5 ± 4.77

364.5 ± 6.10@

341.33 ± 6.23ns

IV

Test I (Betulin 10mg/kg,p.o)

158.66 ± 10.08

249.5 ± 5.85@

237.83 ± 3.63**

V

Test II (Betulin (20mg/kg, p.o)

241.66 ± 6.24

293.33 ± 3.87@

271 ± 4.10ns

VI

Test III (Betulin (40mg/kg, p.o)

212.66 ± 8.28

255.16 ± 3.70@

236.83 ± 16.80***

VII

Test IV (Betulin (Topical)

213.66 ± 12.86

265.33 ± 13.25@

240 ± 13.70*

VIII

Test I + Std. (Betulin + Minoxidil)

214 ± 11.41

267.16 ± 18.12@

245.16 ± 16.26ns

[i] Values expressed as mean ± S. E. M., (n=6,6 and 6) Two way analysis of variance (ANOVA) followed by Bonferroni’s test @P<0.0001 compared to normal and *P<0.05, **P<0.01, ***P<0.001 compared to control.

Figure 5

Results of body weight

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image5.png

Observation shows that after induction of alopecia with testosterone on 22nd day there was significant increase in body weight of animals of all groups as compared to 1st day of study but there was no significant change in weight of normal group animals was decreased after the treatment with standard drug, various doses of betulin and combination of betulin with standard drug on 49th day as compared to 22nd day.

Estimation of Biochemical Parameters

Cholesterol level

The measurement of cholesterol makes it possible to identify hypercholesterolemia, which is linked to hypertriglyceridemia. Elevated cholesterol levels are linked to an increased risk of vascular accidents and the development of atherosclerosis. The ratio should be taken into account when assessing one's risk of cardiovascular disease.

For determination of cholesterol level the collected blood sample was sent to Amey Pathology Laboratory, Socialist Square, Wardha.

Table 4

Observation for cholesterol level

Group No.

Treatment

Cholesterol Level

22nd Day

49th Day

I

Normal (Saline Solution)

51.5 ± 2.71

54.16 ± 3.36

II

Control (Testosterone)

111.33 ± 3.72@

99.66 ± 2.71@

III

Standard (Minoxidil)

112.833 ± 6.81@

66.16 ± 3.71*

IV

Test I (Betulin 10mg/kg,p.o)

114 ± 5.77@

82.83 ± 3.55ns

V

Test II (Betulin (20mg/kg, p.o)

115 ± 7.46@

73.5 ± 5.07ns

VI

Test III (Betulin (40mg/kg, p.o)

126.33 ± 6.82@

59.5 ± 4.63***

VII

Test IV (Betulin (Topical)

121.83 ± 10.18@

60.16 ± 3.32**

VIII

Test I + Std. (Betulin + Minoxidil)

120.33 ± 6.58@

78.5 ± 3.59ns

[i] Values expressed as mean ± S. E. M., (n=6,6 and 6) Two way analysis of variance (ANOVA) followed by Bonferroni’s test @P<0.0001 compared to normal and *P<0.05, **P<0.01, ***P<0.001 compared to control.

Figure 6

Results of cholesterol level

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image6.png

Observation shows that after induction of alopecia with testosterone on 22nd day there was increase in level of cholesterol in blood of animal.

After treatment with standard drug and various doses of Betulin, cholesterol level decreases. Significant decrease observed in animals treated with Betulin 40 mg/kg p.o., Betulin topical and standard drug Minoxidil topical solution where as other group animals treated with betulin 10 mg/kg p.o., betulin 20 mg/kg and combination of test and standard drug does not show significant decrease in cholesterol level in blood of animals. These observations show that Betulin 40 mg/kg p.o. is best effective dose.

Testosterone Level

Elevated testosterone level indicates hyper-androgenism. The collected blood samples by the retro orbital plexus route were sent to Amey Pathology Laboratory, Socialist Square, Wardha. The serum testosterone level was stimulated by Electro chemiluminescence.

Table 5

Observation for testosterone level

Group No.

Treatment

Testosterone Level

22nd Day

49th Day

I

Normal (Saline Solution)

280.94 ± 6.40

276.59 ± 6.58

II

Control (Testosterone)

900.3 ± 13.71@

888.03 ± 10.74@

III

Standard (Minoxidil)

881.3 ± 34.05@

368.04 ± 6.66***

IV

Test I (Betulin 10mg/kg,p.o)

890.11 ± 27.20@

682.12 ± 12.02ns

V

Test II (Betulin (20mg/kg, p.o)

892.76 ± 33.21@

589.21 ± 14.75ns

VI

Test III (Betulin (40mg/kg, p.o)

901.78 ± 26.90@

445.96 ± 12.42*

VII

Test IV (Betulin (Topical)

857.26 ± 36.32@

377.48 ± 12.26**

VIII

Test V (Betulin + Minoxidil)

910.76 ± 17.62@

555.56 ± 14.45ns

[i] Values expressed as mean ± S. E. M., (n=6,6 and 6) Two way analysis of variance (ANOVA) followed by Bonferroni’s test @P<0.0001 compared to normal and *P<0.05, **P<0.01, ***P<0.001 compared to control.

Figure 7

Results of testosterone level

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image7.png

Observation shows that testosterone level increased after induction of alopecia with testosterone on 22nd day but after treatment testosterone level decreased. Treatment with standard drug significantly lowers the testosterone level. Betulin 40mg/kg p.o. and Betulin when applied topically also significantly decreased testosterone level.

Evaluation of Biological Parameters

Skin irritation test

The Betulin (3mg/ml) in Olive Oil was assessed for primary skin irritation test. All group animals were used for the study. Each animal rat was caged individually and food and water given during the test period for 24 hours, prior to the test. The dorsal skin 1cm2 area of animal was cleaned with spirit. Betulin (3mg/ml) solution was topically applied to animals and observed for erythema and edema for 48 hours after application.

Observation found that no erythema and edema occurred in any animal within 48 hours after topical application of Betulin (3mg/ml) solution. It indicated that it is safe for topical use.

Measurement of hair length

Quantitative model for the evaluation of hair growth measurement was performed. Hair was plucked randomly using sterile forceps from the depilated area on 30th day of treatment and the hair length was measured with the help of scale and the results were calculated as mean length ± SEM of 25 hairs.

Table 6

Observation for hair length measurement

Group No.

Treatment

Hair Length (mm) (Mean±SEM)

14th Day

28th Day

I

Normal (Saline Solution)

19.51±0.57

24.12 ± 0.47

II

Control (Testosterone)

14.19±0.28

20.52 ± 0.41

II

Standard (Minoxidil)

22.43±0.56

30.82 ± 0.48***

IV

Test I (Betulin 10mg/kg,p.o)

18.36±0.42

23.41 ± 0.47

V

Test II (Betulin (20mg/kg, p.o)

20.62±0.39

25.61 ± 0.63

VI

Test III (Betulin (40mg/kg, p.o)

20.89±0.47

26.89 ± 0.60*

VII

Test IV (Betulin (Topical)

22.88±0.55

28.09 ± 046**

VIII

Test V (Betulin + Minoxidil)

15.33±0.48

22.89±0.55

[i] Values expressed as mean ± S. E. M., (n = 25 Hairs) @P<0.0001 compared to normal and *P<0.05, **P<0.01, ***P<0.001 compared to control.

After treatment, when hair length was measured it found that length of hair increases. Faster hair growth observed in animals treated with standard drug. Aminals treated with topical Betulin also show hair growth with 28.09mm length as compared with other doses of betulin.

Figure 8

Results of hair length measurement

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image8.png

Histological Study

After the treatment with standard drug and various doses of Betulin, on 28th day of treatment, two rats from each group were selected for cutting the section of the skin. Skin biopsies were obtained from the depilated portion of the rats and preserved in 10% formalin solution. The samples were sent to Amey Pathology Laboratory, Socialist Square, Wardha for the further studies.

Figure 9

Photomicrograph of normal skin of rat

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image9.png

Histopathological section of the normal rat skin shows normal epidermis or dermis layer

Figure 10

Photomicrograph of alopecia induced skin of rat

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image10.png

Histopathological section of alopecia induced induced skin shows heavy infiltration of lymphocytes, plasma cells, macrophages in deep dermis. Epidermis shows diffuse atrophy and ballooning degerneration. Histological features thus suggested the appearance of Chronic Dermatitis.

Figure 11

Photomicrograph of rat skin treated with standard drug(Minoxidil)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image11.png

Histopathological section of the standard drug treated skin shows no remarkable changes in epidermis or dermis means Minoxidil repair the changes occur after induction of alopecia. Thus histological features are within normal limits.

Figure 12

Photomicrograph of rat skin treated with betulin 10mg/kg p.o.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image12.png

Histological section of the skin treated with Betulin 10mg/kg p.o. shows diffuse degeneration of keratocytes, flattening of epidermis, acantholysis. There is heavy infiltration of lymphocytes in deep dermis. This histological feature indicates drug/chemical induced dermatitis.

Figure 13

Photomicrograph of rat skin treated with Betulin 20mg/kg p.o.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image13.png

Histopathological section of skin treatment with Betulin 20mg/kg p.o. shows spongiosis, diffuse atrophy of squamous epithelium and ballooning. It also shows degeneration of basal cells of epidermis. Section shows dermal adnexae are normal. These histological feature are indicates that all changes are drug/chemical induced changes.

Figure 14

Photomicrograph of rat skin treated with Betulin 40mg/kg p.o.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image14.png

Histopathological section of the skin treated with Betulin 40mg/kg p.o. shows no remarkable changes in epidermis or dermis which may due to restoration of the changes observed during induction of alopecia.

Figure 15

Photomicrograph of rat skin treated with Betulin topical solution

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image15.png

Histopathological section of the skin treated with Betulin Topical shows no remarkable changes in epidermis or dermis. Betulin Topical repair the changes occur after induction of alopecia. Thus histological features are with normal limits.

Figure 16

Photomicrograph of rat skin treated with combination of test and standard drug

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e135620c-718a-498a-866f-1c97e150f542image16.png

Histopathological section of skin treated with test drug i.e. Betulin 10mg/kg p.o. and Standard drug (Minoxidil) shows epitheloid granulomas, Langhan’s Giant cell, necrosis in deep dermis. Epidermis is histologically unremarkable. Histological feature indicate appearance of Tuberculosis.

Statistical Analysis

Data were analysed using Graph Pad Prism 5 for Windows (version 5.00). Results expressed as Mean ± SEM. Two-way analysis of variance (ANOVA), Bonferroni’s and Tukey’s post-test were used to test the significance of the difference between the variables in various groups. The P values of less than 0.05 were considered to be statistically significant.

Discussion

Hair has been sign of beauty and a contribution to an individual personality. Many factors such as metabolism, hormones, heredity and side effects of anti-neoplastic and immune suppressant drugs are negatively affects the healthy growth of hair and results in hair loss that generally called alopecia. It is common throughout the world.7

Androgens like testosterone are mediators of terminal hair growth all through the body. An elevated testosterone level is not the cause of hair loss. Dihydrotestosterone (DHT) (metabolised form of testosterone) is more potent androgen, is responsible for hair loss.14

Hair loss results when certain hair follicles on scalp are highly sensitive to DHT. As a result of this sensitivity, hair follicles shrink and eventually disappear. Based on these findings, DHT is held responsible for miniaturization of hair follicles in androgenic alopecia. 15

There are number of ways by which drug may stimulate hair growth like it may increase the linear growth rate of hair, increase the diameter of the hair fibre, alter the hair cycle, either shortening telogen or prolonging anagen or act through a combination of both effects.

Minoxidil (Topical) is the FDA approved drug used for the treatment of alopecia.

Minoxidil is a vasodilator and potassium channel opener known to prolong the anagen phase and converts vellus hair to terminal hair. Minoxidil solutions causes scalp irritation, headaches, dizzy spells, itchiness, redness, contact dermatitis.

Various researches shows that betulin (Triterpene) exhibit a wide range of activities like antimicrobial activity, anit-inflammatory, antiviral, hepatoprotective and anticancer. Triterpenes now a day’s mostly used for cosmetic applications. Highly pure betulin widely used in the pharmaceutical and cosmetic industries. Betulin and its semisynthetic derivatives have high potential in medicine. 14

Betulin occurs in a number of plants, especially in many species of birch, where it found in large amount in the outer bark.8 Triterpenoid like Lupeol, Betulinic acid present in different plants like Birch bark, Careya Arborea, Alangium salvifolium and Alstonia scholaris are used in the hair conditioners and shampoos. They help to reduce hair loss, improve keratin absorption, reduce inflammation and inhibit bacterial growth.16

Literature survey shows that Betulin is a triterpenoid also used in the hair conditioners and shampoos since 19th century. Some studies shows that increase in the cholesterol level causes the hair loss and betulin was found to lower the cholesterol level hence it may inhibit the hair loss. By considering the above fact we investigated hair growth promoting activity of betulin on testosterone induced alopecia.

In present study testosterone (0.5 mg/kg) subcutaneously administered for 21 days to rats for induction of alopecia. The fall of hair and appearance of baldness (Figure 4) confirmed the induction of alopecia. The alopecia developed by testosterone may be due to the high sensitive of hair follicles toward DHT. As a result of this sensitivity, hair follicles shrink and eventually disappear. It was further confirmed by determination of various parameters.

The body weight of animals significantly increase after induction of alopecia with testosterone on 22nd day (Table 3 and Figure 5). Whereas body weight of animals of all groups except normal group animals was decreased after the treatment with standard drug, various doses of betulin and combination of betulin with standard drug on 49th day. Some studies have suggested that chronic administration of testosterone, increase body weight and body fat in experimental animals. Testosterone might disturb the mechanism that protect against adiposity and hyperphagia and represent the risk factor for excessive body and obesity. 17

Observation of biochemical parameters shows that cholesterol and testosterone level increased after induction of alopecia (Table 4 and 5) (Figure 6, Figure 7). Testosterone level increased because it is used as an inducer and cholesterol level increased may be due to testosterone which may increase in microsomal enzyme activity, resulting in increased cholesterol production by the liver.

After treatment with standard drug and various doses of betulin, cholesterol level decreased. Betulin, may decreased the biosynthesis of cholesterol and fatty acid by specially inhibiting the maturation of sterol regulatory element-binding proteins (SREBP).9

Minoxidil also decreased the cholesterol and testosterone level but its mechanism of action have still not been comprehensively understood but one of the in-vitro study shows that Minoxidil changes the activity of 5-α-reductase type 2 inhibitor. This anti-androgenic effect of minoxidil, shows by significant down regulation of 5α-R2 gene expression in HaCat cells, may be one of its mechanism of action in alopecia. 18

For testing the safety of betulin, skin irritancy test was performed on animals. Observation found that no erythema and edema occurred in any animal within 48hours after topical application of Betulin (3mg/ml) solution. It indicated that it is safer for topical use.

For checking the hair growth promoting effect of standard drug Minoxidil and betulin, hair length was measured two times i.e. after 14th and 28th day of treatment. Faster hair growth observed in animals treated with standard drug with hair length 30.82mm. Animals treated with topical topical betulin also show hair growth with 28.09mm as compared with other doses of betulin (Table 6 and Figure 8). The results of betulin indicates that topical application of betulin shows better and fast hair growth than use of oral betulin. Topical betulin shows better effect may be due to more absorption in the skin as it used along with olive oil. Olive oil contains hydrophilic phenols which are rich in antioxidants effect and thus it has benn used as a skin product and hair cosmetic.

For the checking of induction of alopecia, the histopathology study was conducted. Histopathological section of alopecia induced skin shows heavy infiltration of lymphocytes, plasma cells, macrophages in deep dermis. Epidermis shows diffuse atrophy and ballooning degeneration, which results in appearance of Chronic Dermatitis (Figure 10). These features indicated the induction of alopecia.

For the checking hair growth effect of betulin, the histopathology study was conducted. Histopathological section of the skin treated with Betulin 40 mg/kg p.o. and skin treated with Betulin Topical shows no remarkable changes in epidermis or dermis which means that betulin restore the changes which observed in alopecia induced skin, may be due to its antioxidant potency.

The histopathology of skin treated with test drug i.e. Betulin 10 mg/kg p.o. and standard drug (Minoxidil) shows epitheloid granulomas, langhan’s giant cells, necrosis in deep dermis. Histologically epidermis is unremarkable. All these histological features indicate appearance of Tuberculosis. The cause of such effect is unknown.

Conclusion

The present study showed that Betulin, a triterpenoid, effective against testosterone induced alopecia. It decreases the level of testosterone and ultimately level of DHT which mainly responsible for the hair loss. Various doses of betulin work against alopecia but topical application show better effect. Topical betulin shows better effect may be due to more absorption in the skin as it used along with olive oil which antioxidants. A histopathological observation also proves these results of betulin.

Source of Funding

None.

Conflict of Interest

None.

References

1 

S Helfert P Warschburger The face of appearance-related social pressure: gender, age and body mass variations in peer and parental pressure during adolescence. Child Adolescent Psychiatry Mental Health201371116

2 

R Suraja G Rejitha A Jeba SB Anandarajagopala K Promwichita In vivo hair growth activity of Prunus dulcis seeds in ratsBiol Med2009143442

3 

S Anarthe BJ Reddy MP Uttam MG Raju Evaluation of Polyherbal Formulation of Some Traditional Medicinal Plants for Hair Growth Promoting Activity2014415269

4 

S Upadhyay PU Ghosh V Singh Study of protective effect of Glycyrrhetinic acid in androgen induced alopeciaRes Pharm20188102

5 

J Birnbaum Hair growth compositions and methods for treating hair loss or related conditions.United States patent application US 11/530,501200713

6 

A Alkhalifah A Alsantali E Wang KJ Mcelwee J Shapiro Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesisJ Am Acad Dermatol201062217788

7 

M Semalty A Semalty GP Joshi MS Rawat Hair growth and rejuvenation: an overviewJ Dermatol Treat201122312355

8 

P Šiman A Filipová A Tichá M Niang A Bezrouk R Havelek Effective method of purification of betulin from birch bark: The importance of its purity for scientific and medicinal usePloS one2016115154933

9 

JJ Tang JG Li W Qi WW Qiu PS Li BL Li Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques.Cell Metab2011134456

10 

A Boparai J Niazi N Bajwa PA Singh Betulin a pentacyclic tri-terpenoid: an hour to rethink the compoundOpen Access J Trans Med Res201712539

11 

K Upadhyay NK Gupta VK Dixit Development and characterization of phyto-vesicles of β-sitosterol for the treatment of androgenetic alopecia.Arch Dermatol Res201230451120

12 

O Mori H Uno The effect of topical minoxidil on hair follicular cycles of rats.J Dermatol199017527681

13 

TK Lin L Zhong JL Santiago Anti-inflammatory and skin barrier repair effects of topical application of some plant oils. Int J Mol Sci20171917010.3390/ijms19010070

14 

KD Kaufman Androgens and alopeciaMol Cell EndocrinoL20021988995

15 

S Patel MK Nag V Sharma NS Chauhan VK Dixit A comparative in vivo and in vitro evaluation of hair growth potential of extracts and an isolate from petroleum ether extract of Cuscuta reflexa RoxbBeni-Suef University J Basic Appl Sci20143316571Beni-

16 

GA Tolstikov OB Flekhter EE Shultz LA Baltina AG Tolstikov Betulin and its derivatives. Chemistry and biological activity.Chem Sustainable Dev200513129

17 

T Iwasa T Matsuzaki K Yano R Yanagihara A Tungalagsuvd M Munkhzaya The effects of chronic testosterone administration on body weight, food intake, and adipose tissue are changed by estrogen treatment in female rats. Hormones and Behavior20175361

18 

E Pekmezci M Türkoğlu Minoxidil acts as an antiandrogen: A study of 5α-reductase zype 2 gene expression in a human keratinocyte cell lineActa Dermatovenerologica Croatica20172542715



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.